Man Announces That He Has Synthesized a New Schizophrenia Treatment in His Garage, Based on a Formula Devised by ChatGPT

Douglas Yao, a biochemist working independently in his garage, has synthesized a new schizophrenia drug called PAC-3310, designed with ChatGPT's help. He claims it improves on the recently approved antipsychotic Cobenfy and is testing it in cell lines and mice, aiming to reduce drug development costs significantly.